Predictors of consenting to participate in a clinical trial among urban cancer patients.

Saved in:
Bibliographic Details
Title: Predictors of consenting to participate in a clinical trial among urban cancer patients.
Authors: McIntire RK; Jefferson College of Population Health, Thomas Jefferson University, 901 Walnut St., 10(th) Floor, Philadelphia, PA 19107, United States of America. Electronic address: Rum222@lehigh.edu., Keith SW; Division of Biostatistics, Department of Pharmacology, Physiology, & Cancer Biology, Thomas Jefferson University, 130 S 9(th) St., 17(th) Floor, Philadelphia, PA 19107, United States of America., Nowlan T; Jefferson College of Population Health, Thomas Jefferson University, 901 Walnut St., 10(th) Floor, Philadelphia, PA 19107, United States of America., Butt S; Jefferson College of Population Health, Thomas Jefferson University, 901 Walnut St., 10(th) Floor, Philadelphia, PA 19107, United States of America., Cambareri K; Jefferson College of Population Health, Thomas Jefferson University, 901 Walnut St., 10(th) Floor, Philadelphia, PA 19107, United States of America., Callaghan J; Jefferson College of Population Health, Thomas Jefferson University, 901 Walnut St., 10(th) Floor, Philadelphia, PA 19107, United States of America., Halstead T; Jefferson College of Population Health, Thomas Jefferson University, 901 Walnut St., 10(th) Floor, Philadelphia, PA 19107, United States of America., Chandrasekar T; Department of Urology, Thomas Jefferson University, 1025 Walnut Street, Suite 1112, Philadelphia, PA 19107, United States of America., Kelly WK; Division of Solid Tumor Oncology, Department of Medical Oncology, Thomas Jefferson University, 925 Chestnut Street, Suite 220A, Philadelphia, PA 19107, United States of America., Leader AE; Division of Population Science, Department of Medical Oncology, Thomas Jefferson University, 834 Chestnut St., Benjamin Franklin House, Suite 320, Philadelphia, PA 19107, United States of America.
Source: Contemporary clinical trials [Contemp Clin Trials] 2023 Feb; Vol. 125, pp. 107061. Date of Electronic Publication: 2022 Dec 22.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 101242342 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1559-2030 (Electronic) Linking ISSN: 15517144 NLM ISO Abbreviation: Contemp Clin Trials Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1559-2030
DOI:10.1016/j.cct.2022.107061